Latest Rovi News & Updates
See the latest news and media coverage for Rovi. We track all announcements, press releases, and industry mentions in real time, all in one place.
Specialty pharmaceutical company
rovi.es- Headquarters
- Madrid, Spain
- Founded year
- 1946
- Company type
- Private company
- Number of employees
- 1,400–5,000
Last updated
Latest news about Rovi
In short: Rovi completed the acquisition of a Phoenix manufacturing plant and signed a strategic manufacturing agreement with Roche to drive growth through 2030.
Company announcements
-
Laboratorios ROVI publishes 1Q 2026 results
Operating income reaches 152.5 million euros. CDMO grows 5%, Risperidona ISM® 37%. R&D investment rises 79% to 11.2 million.
-
Rovi reports Q1 2026 revenue of 154.7 million euros
Gross margin expands 3.8 points to 62.3%. Heparin sales drop 12%, Okedi rises 37%. Updates 2026 guidance to low-to-mid single-digit growth. Announces plant acquisition completion.
-
Rovi presents 1Q2026 results tomorrow
Beatriz de Zavala Mazarredo will present them in streaming with Estrategias de inversión at 12:30 p.m.
-
Rovi presents 1Q 2026 results
Beatriz de Zavala Mazarredo will present them on May 6 at 11:00 in live broadcast.
Media coverage
-
Laboratorios Farmaceuticos Rovi SA (WBO:ROVI) Q1 2026 Earnings Call Highlights:...
This article first appeared on GuruFocus. Operating Revenues: EUR152.5 million, a 1.5% decrease compared to Q1 2025. Gross Profit: EUR95 million, a 5% increase with...
-
Rovi worsens its stock market fall: wipes out nearly 1,000 million after plummeting 20% in two sessions
The pharmaceutical company accumulates a 20% plunge since it lowered its forecasts this Wednesday although analysts reiterate that it is an adjustment of the...
-
The Ibex 35 consolidates the 18,000 points awaiting Iran and the US. Sabadell, the good side and Rovi, the bad side
The Spanish stock market hovers around opening levels to close this Thursday with a small adjustment after yesterday's important rises, very attentive...
-
Stock market crash (-15%) for Rovi: it plummets due to the downgrade in its forecasts
The pharmaceutical company has announced a net profit of 9.4 million euros in the first quarter of the year, a figure 48% lower than that of...
Track Rovi and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Rovi competitors & trending companies
Browse news for competitors to Rovi and other trending companies.
Recipharm
Pit
Davis AI
Qutwo
DigiPowerX
Penguin Solutions
Sterling Infrastructure
KIOXIA Corporation
Subquadratic
Tibber
IREN
A24
Hitachi Energy
Ouster
Ormat Technologies
Fabrinet
AOI
WidePoint
Filtronic
Mirum Pharmaceuticals
Capstone Green Energy
AXT
POET Technologies
PurpleFire
Profitable Media
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove